The comorbidities associated with multiple sclerosis are known to significantly worsen inflammation and hasten disease progression. When relief with pharmacologic agents is inadequate, what concerns may hinder clinicians about turning to nonpharmacologic methods?
How useful is neuromodulation in improving spasticity and gait dysfunction? Can behavioral training address MS-related cognition deficits? Is there anything more effective than the commonly prescribed medications to relieve MS fatigue? What does the evidence say?
These are some of the key questions Dr. Oliver Tobin at the Mayo Clinic addresses in this issue of eMultipleSclerosis Review.
Assistant Professor
Department of Neurology
Johns Hopkins School of Medicine
Baltimore, MD
Department of Neurology
Johns Hopkins Hospital
Baltimore, MD
Assistant Professor
Department of Neurology
Johns Hopkins School of Medicine
Baltimore, MD
1.0 hour Physicians
1.0 contact hour Nurses
Launch date: March 10, 2022
Expiration date: March 9, 2024